DK554585A - Laegemiddel omfattende en forbindelse af mindst et immunotoxin og mindst en mannoseholdig polymer - Google Patents

Laegemiddel omfattende en forbindelse af mindst et immunotoxin og mindst en mannoseholdig polymer Download PDF

Info

Publication number: DK554585A
Authority: DK; Denmark
Prior art keywords: immunotoxin; mannose; containing polymer; compound; pharmaceutical including
Prior art date: 1984-11-29

Application number

DK554585A

Other languages

English (en)

Other versions

DK554585D0 (da

DK163030C (da

DK163030B (da

Inventor

Pierre Casellas

Bernard Bourrie

Pierre Gros

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-11-29

Filing date

1985-11-29

Publication date

1986-05-30

1985-11-29 Application filed by Sanofi Sa filed Critical Sanofi Sa

1985-11-29 Publication of DK554585D0 publication Critical patent/DK554585D0/da

1986-05-30 Publication of DK554585A publication Critical patent/DK554585A/da

1992-01-13 Publication of DK163030B publication Critical patent/DK163030B/da

1992-06-15 Application granted granted Critical

1992-06-15 Publication of DK163030C publication Critical patent/DK163030C/da

Links

229940051026 immunotoxin Drugs 0.000 title abstract 3
230000002637 immunotoxin Effects 0.000 title abstract 3
239000002596 immunotoxin Substances 0.000 title abstract 3
231100000608 immunotoxin Toxicity 0.000 title abstract 3
229920000642 polymer Polymers 0.000 title abstract 2
150000001875 compounds Chemical class 0.000 title 1
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 abstract 1
230000008030 elimination Effects 0.000 abstract 1
238000003379 elimination reaction Methods 0.000 abstract 1
238000002347 injection Methods 0.000 abstract 1
239000007924 injection Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK554585A 1984-11-29 1985-11-29 Laegemidler, der er emballeret med henblik paa administration ved injektion DK163030C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR8418203A FR2573656B1 (fr)	1984-11-29	1984-11-29	Medicament comportant en tant qu'association au moins une immunotoxine et au moins un polymere contenant du mannose
FR8418203		1984-11-29

Publications (4)

Publication Number	Publication Date
DK554585D0 DK554585D0 (da)	1985-11-29
DK554585A true DK554585A (da)	1986-05-30
DK163030B DK163030B (da)	1992-01-13
DK163030C DK163030C (da)	1992-06-15

Family

ID=9310066

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK554585A DK163030C (da)	1984-11-29	1985-11-29	Laegemidler, der er emballeret med henblik paa administration ved injektion

Country Status (13)

Country	Link
US (1)	US4749566A (da)
EP (1)	EP0186551B1 (da)
JP (1)	JPH062679B2 (da)
AT (1)	ATE49708T1 (da)
AU (1)	AU588008B2 (da)
CA (1)	CA1254139A (da)
DE (1)	DE3575521D1 (da)
DK (1)	DK163030C (da)
FR (1)	FR2573656B1 (da)
IE (1)	IE58776B1 (da)
IL (1)	IL77168A0 (da)
NZ (1)	NZ214357A (da)
ZA (1)	ZA859120B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5185434A (en) *	1985-02-13	1993-02-09	Sanofi	Prolonged-action immunotoxins containing a glycopeptide constituent which inactivates ribosomes, modified on its polysaccharide units
EP0303681B1 (en) *	1987-02-24	1992-10-14	Xoma Corporation	Immunosuppression in immunotoxin based human therapy
US4946675A (en) *	1987-05-27	1990-08-07	Xoma Corporation	Hepatic blocking agents
GB8809616D0 (en) *	1988-04-22	1988-05-25	Cancer Res Campaign Tech	Further improvements relating to drug delivery systems
US5632990A (en) *	1988-04-22	1997-05-27	Cancer Research Campaign Tech. Ltd.	Treatment for tumors comprising conjugated antibody A5B7 and a prodrug
US5112607A (en) *	1991-06-05	1992-05-12	The United States Of America As Represented By The Secretary Of The Army	Potentiation of immunotoxin action by Brefeldin A
FR2802536B1 (fr) *	1999-11-23	2003-06-13	Chru Lille	Oligomannosides de synthese, leur preparation et leur utilisation a la detection d'anticorps et a la prevention d'infections
MX2007013725A (es)	2005-05-05	2008-04-09	Sensient Flavors Inc	Produccion de beta-glucanos y mananos.
BR112012028893A2 (pt)	2010-05-10	2017-12-12	Ascend Biopharmaceuticals Pty Ltd	composições imunoestimuladoras e de vacina
US20120177567A1 (en) *	2010-08-11	2012-07-12	National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government	Methods of Treating Pediatric Acute Lymphoblastic Leukemia with an Anti-CD22 Immunotoxin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2504010B1 (fr) *	1981-04-15	1985-10-25	Sanofi Sa	Medicaments anticancereux contenant la chaine a de la ricine associee a un anticorps antimelanome et procede pour leur preparation
FR2516794B1 (fr) *	1981-11-20	1985-10-25	Sanofi Sa	Nouveaux medicaments anticancereux pour le traitement des leucemies t constitues de la chaine a de la ricine et d'un anticorps monoclonal specifique
FR2521010B1 (fr) *	1982-02-09	1985-07-19	Sanofi Sa	Medicaments comportant en tant qu'association au moins une immunotoxine et au moins un ionophore carboxylique monovalent
FR2522968B1 (fr) *	1982-03-10	1986-03-28	Sanofi Sa	Medicament cytotoxique forme de l'association d'a u moins une immunotoxine et de la chloroquine
FR2536997B1 (fr) *	1982-03-11	1987-08-07	Sanofi Sa	Medicaments cytotoxiques comportant au moins une immunotoxine et de la methylamine
FR2523445A1 (fr) *	1982-03-17	1983-09-23	Sanofi Sa	Nouveaux conjugues associant, par liaison covalente, une enzyme et un anticorps, et associations medicamenteuses utilisant lesdits conjugues
FR2577135B1 (fr) *	1985-02-13	1989-12-15	Sanofi Sa	Immunotoxines a longue duree d'action comportant un constituant glycopeptidique inactivant les ribosomes modifie sur ses motifs polysaccharidiques

1984
- 1984-11-29 FR FR8418203A patent/FR2573656B1/fr not_active Expired
1985
- 1985-11-26 US US06/801,843 patent/US4749566A/en not_active Expired - Fee Related
- 1985-11-27 DE DE8585402319T patent/DE3575521D1/de not_active Expired - Fee Related
- 1985-11-27 AT AT85402319T patent/ATE49708T1/de not_active IP Right Cessation
- 1985-11-27 IL IL77168A patent/IL77168A0/xx not_active IP Right Cessation
- 1985-11-27 EP EP85402319A patent/EP0186551B1/fr not_active Expired - Lifetime
- 1985-11-28 IE IE299285A patent/IE58776B1/en not_active IP Right Cessation
- 1985-11-28 AU AU50473/85A patent/AU588008B2/en not_active Ceased
- 1985-11-28 ZA ZA859120A patent/ZA859120B/xx unknown
- 1985-11-28 NZ NZ214357A patent/NZ214357A/xx unknown
- 1985-11-28 CA CA000496389A patent/CA1254139A/en not_active Expired
- 1985-11-29 DK DK554585A patent/DK163030C/da not_active IP Right Cessation
- 1985-11-29 JP JP60269192A patent/JPH062679B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
IL77168A0 (en)	1986-04-29
IE852992L (en)	1986-05-29
US4749566A (en)	1988-06-07
NZ214357A (en)	1990-02-26
DK554585D0 (da)	1985-11-29
EP0186551A1 (fr)	1986-07-02
DE3575521D1 (de)	1990-03-01
CA1254139A (en)	1989-05-16
FR2573656B1 (fr)	1987-02-27
DK163030C (da)	1992-06-15
JPH062679B2 (ja)	1994-01-12
DK163030B (da)	1992-01-13
ATE49708T1 (de)	1990-02-15
FR2573656A1 (fr)	1986-05-30
IE58776B1 (en)	1993-11-17
ZA859120B (en)	1986-08-27
EP0186551B1 (fr)	1990-01-24
AU588008B2 (en)	1989-09-07
JPS61197528A (ja)	1986-09-01
AU5047385A (en)	1986-06-05

Legal Events

Date	Code	Title	Description
1995-07-24	PBP	Patent lapsed

Publication	Publication Date	Title
MX9203373A (es)	1992-09-01	3-amino-1-hidroxi-propan-1,1-difosfonato disodico y composiciones farmaceuticas que lo contienen.
DE3585294D1 (de)	1992-03-12	Molekularsiebzusammensetzungen.
FI931031A0 (fi)	1993-03-09	Mometasonfuroatmonohydrat, foerfarande foer dess framstaellning och farmaceutiska sammansaettningar
DE3584905D1 (de)	1992-01-30	Molekularsiebzusammensetzungen.
IT1212778B (it)	1989-11-30	Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
DK0705100T3 (da)	2003-11-17	Terapeutiske substituerede guanidiner
DK554585D0 (da)	1985-11-29	Laegemiddel omfattende en forbindelse af mindst et immunotoxin og mindst en mannoseholdig polymer
DE3576488D1 (de)	1990-04-19	Molekularsieb-zusammensetzungen.
SE8202380L (sv)	1982-10-17	Analgetisk komposition
IT1214671B (it)	1990-01-18	Metodo per inibire l'insorgere di sindrome da radiazioni e composizione diendotossina detossificata impiegata a tale scopo
KR950700721A (ko)	1995-02-20	순한 샴푸 조성물(mild shampoo compositions)
SE9201189L (sv)	1992-04-14	Foerbaettringar vid organiska foereningar
IT1290797B1 (it)	1998-12-11	Composizioni farmaceutiche stabilizzate
FI933477A0 (fi)	1993-08-05	Monohydrat av ett dinatriumsalt av 4-klorfenyltiometylenbisfosfonsyra,dess framstaellning och farmaceutiska kompositioner innehaollande detta
FI913639A7 (fi)	1992-02-01	Farmaceutiska kompositioner.
FI962979L (fi)	1996-07-26	Hirudiinia sisältävät farmaseuttiset koostumukset
FI915801A0 (fi)	1991-12-10	Komposition och foerfarande foer att foerhindra fluoros.
PT81280B (pt)	1988-02-17	Processo para a preparacao de composicoes melhoradas de medicamentos anti-inflamatorios contendo idometacina ou um oxicamo
PT73339B (fr)	1982-07-30	Compositions stabilisees de 1,1,1-trichloroethane
FI812369A7 (fi)	1982-02-05	Injektoitavat farmaseuttiset koostumukset.
FI910773A0 (fi)	1991-02-18	Farmaceutisk komposition innehaollande ett episialo-kolhydratkomplex.
DE3381157D1 (de)	1990-03-01	Kabelverzweigungsabdeckung.
MX9202984A (es)	1992-07-01	Composiciones farmaceuticas que contienen salbutamol.
IT8422898A0 (it)	1984-09-28	Derivati di 1,4-diidropiridina e composizioni farmaceutiche che licontengono.
MX9204164A (es)	1993-05-01	Composicion farmaceutica que comprende arndh.